Cargando…
Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with ‘Actionable’ Pulmonary Nodules
SIMPLE SUMMARY: Circulating biomarkers for the identification of patients with “actionable” nodules may increase screening uptake and decrease false-positive rates associated with low-dose computed tomography (LDCT). Novel autoantibody biomarkers were identified utilizing a HuProt™ protein microarra...
Autores principales: | Auger, Claire, Moudgalya, Hita, Neely, Matthew R., Stephan, Jeremy T., Tarhoni, Imad, Gerard, David, Basu, Sanjib, Fhied, Cristina L., Abdelkader, Ahmed, Vargas, Moises, Hu, Shaohui, Hulett, Tyler, Liptay, Michael J., Shah, Palmi, Seder, Christopher W., Borgia, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136536/ https://www.ncbi.nlm.nih.gov/pubmed/37190187 http://dx.doi.org/10.3390/cancers15082259 |
Ejemplares similares
-
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer
por: Pohlman, Alexander W., et al.
Publicado: (2022) -
Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer
por: Wakefield, Connor J., et al.
Publicado: (2021) -
The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer
por: Wakefield, Connor J., et al.
Publicado: (2022) -
Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules
por: Huo, Yunli, et al.
Publicado: (2020) -
The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules
por: Ling, Zhougui, et al.
Publicado: (2021)